Evidence-Based Diabetes Management > April 2015

Evidence-Based Diabetes Management - April 2015

April 29, 2015 – Mary K. Caffrey
Studies have shown that embedding behavioral health services into the primary care practice produces better health outcomes for patients with diabetes, while reducing indications of depression. The challenge is figuring out how to make the transition to new payment models that reward such care.
May 04, 2015 – Andrew Smith
Real-world studies of SGLT2 inhibitors show that this new class of drugs for type 2 diabetes has lowered A1C more than rivals. Patients lose more weight than with other oral therapies, and the benefit of controlling hypertension may make it possible for some patients to stop taking other drugs.
May 05, 2015 – Surabhi Dangi-Garimella, PhD
A study published in JAMA Surgery compared long-term weight loss and other outcomes, along with adverse effects, of different surgical methods for weight loss.
May 05, 2015 – Mary K. Caffrey
The argument for cost-effectiveness has become important in the care of patients with diabetes and other comorbidities, as patients typically take multiple medications, each with its own cost-both to the payer and to the patient in the form of a co-pay-as well as some side effects.
May 05, 2015 – Tony Hagen
CMS' decision to pay primary care physicians to coordinate for seniors with multiple chronic conditions cannot soon enough, if a study in Clinical Diabetes is any sign.
May 05, 2015 – Mary K. Caffrey
Several recent studies have singled out too much TV watching as being associated with a higher risk of all cause mortality and a string of health problems, from diabetes and obesity to colorectal cancer.
May 05, 2015 – Tony Hagen
When 5% of Medicaid recipients account for 54% of spending, cost is just the beginning of the problem.
May 05, 2015 – Robert A. Gabbay, MD, PhD, FACP
Joslin Diabetes Center has earned the highest level of recognition from the National Committee for Quality Assurance, which cited the center's strengths in communication, access, and coordination of care in the citation for a Patient-Centered Specialty Practice.
May 05, 2015 – Mary K. Caffrey
The meta-analysis in Annals of Internal Medicine found that small doses of exercise were not enough to offset the effects of long periods of sitting on all-cause mortality and chronic disease, including diabetes.
May 05, 2015 – Andrew Smith
Saxenda was approved in December 2014 to treat obesity, giving physicians another option for patients who are overweight and battling diabetes. Experts say payers need to take obesity as seriously as other conditions when making decisions about covering therapies.
May 06, 2015 – Mary K. Caffrey
FDA approves a key combination therapy for type 2 diabetes mellitus, a device to help patients battle obesity, and another indication for Lucentis.
May 06, 2015 – Mary K. Caffrey
Among other topics, panelists discussed the connection between mental health and diabetes, and the need to treat these conditions together.
May 06, 2015 – Mary K. Caffrey
Lancet editors criticized the "unacceptably slow" global response to rising rates of childhood obesity.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.